APTO
Price
$0.24
Change
-$0.04 (-14.29%)
Updated
Dec 23, 04:59 PM (EDT)
SLNO
Price
$44.97
Change
-$0.21 (-0.46%)
Updated
Dec 23, 04:59 PM (EDT)
91 days until earnings call
Ad is loading...

APTO vs SLNO

Header iconAPTO vs SLNO Comparison
Open Charts APTO vs SLNOBanner chart's image
Aptose Biosciences
Price$0.24
Change-$0.04 (-14.29%)
Volume$10.64K
CapitalizationN/A
Soleno Therapeutics
Price$44.97
Change-$0.21 (-0.46%)
Volume$8.26K
CapitalizationN/A
APTO vs SLNO Comparison Chart
Loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTO vs. SLNO commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTO is a StrongBuy and SLNO is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (APTO: $0.25 vs. SLNO: $44.94)
Brand notoriety: APTO and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTO: 92% vs. SLNO: 62%
Market capitalization -- APTO: $14.67M vs. SLNO: $1.94B
APTO [@Biotechnology] is valued at $14.67M. SLNO’s [@Biotechnology] market capitalization is $1.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTO’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • APTO’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both APTO and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTO’s TA Score shows that 6 TA indicator(s) are bullish while SLNO’s TA Score has 5 bullish TA indicator(s).

  • APTO’s TA Score: 6 bullish, 4 bearish.
  • SLNO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APTO is a better buy in the short-term than SLNO.

Price Growth

APTO (@Biotechnology) experienced а +31.50% price change this week, while SLNO (@Biotechnology) price change was -6.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

APTO is expected to report earnings on Aug 10, 2023.

SLNO is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($1.94B) has a higher market cap than APTO($14.7M). SLNO YTD gains are higher at: 11.665 vs. APTO (-90.205). APTO has higher annual earnings (EBITDA): -35.78M vs. SLNO (-136.5M). SLNO has more cash in the bank: 257M vs. APTO (8.33M). SLNO has less debt than APTO: SLNO (3.03M) vs APTO (10.7M). APTO (0) and SLNO (0) have equivalent revenues.
APTOSLNOAPTO / SLNO
Capitalization14.7M1.94B1%
EBITDA-35.78M-136.5M26%
Gain YTD-90.20511.665-773%
P/E RatioN/AN/A-
Revenue00-
Total Cash8.33M257M3%
Total Debt10.7M3.03M353%
FUNDAMENTALS RATINGS
APTO vs SLNO: Fundamental Ratings
APTO
SLNO
OUTLOOK RATING
1..100
2452
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6560
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APTO's Valuation (90) in the Biotechnology industry is in the same range as SLNO (99) in the Medical Specialties industry. This means that APTO’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for APTO (100) in the Biotechnology industry. This means that SLNO’s stock grew somewhat faster than APTO’s over the last 12 months.

SLNO's SMR Rating (98) in the Medical Specialties industry is in the same range as APTO (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to APTO’s over the last 12 months.

SLNO's Price Growth Rating (60) in the Medical Specialties industry is in the same range as APTO (65) in the Biotechnology industry. This means that SLNO’s stock grew similarly to APTO’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as APTO (100) in the Biotechnology industry. This means that SLNO’s stock grew similarly to APTO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOSLNO
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
84%
View a ticker or compare two or three
Ad is loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOMZ0.800.03
+3.46%
TOMI Environmental Solutions
GEF60.760.44
+0.73%
Greif
ZTO19.80-0.03
-0.15%
ZTO Express (Cayman)
JYNT10.07-0.20
-1.95%
Joint Corp (The)
LAZR5.04-0.26
-4.91%
Luminar Technologies Inc

APTO and

Correlation & Price change

A.I.dvisor tells us that APTO and LCTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTO and LCTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTO
1D Price
Change %
APTO100%
-10.82%
LCTX - APTO
31%
Poorly correlated
-1.70%
BDTX - APTO
30%
Poorly correlated
-1.35%
LOGC - APTO
28%
Poorly correlated
-1.93%
MDGL - APTO
28%
Poorly correlated
+0.79%
SLNO - APTO
28%
Poorly correlated
-0.52%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-0.52%
BRNS - SLNO
56%
Loosely correlated
+4.50%
KANT - SLNO
45%
Loosely correlated
-8.56%
XENE - SLNO
42%
Loosely correlated
-1.27%
ACLX - SLNO
40%
Loosely correlated
+1.65%
KYMR - SLNO
39%
Loosely correlated
+0.32%
More